Insect protein

Highlights

  • Insect protein innovation is maturing, not shrinking. Outside China, insect protein patent filings have eased from their 2020 peak but remain well above pre-pandemic levels.
  • Insect protein innovators are becoming more selective about where they protect their inventions. Fewer inventions are being filed on internationally. Applicants appear to be more cautious about IP spend, or more focused on their home markets.
  • Black soldier fly remains the leading insect species for patenting, but mealworm is gaining ground.Asia is the centre of insect protein patenting. South Korea leads outside China, India is growing, and China is rebounding and is by far the largest filer. European filings have pulled back.
  • Insect protein patents on production and automation technologies still make up most filings, in line with the long-run norm.
  • No single applicant dominates. Public bodies, universities and specialist companies all feature, including newcomers.

Market context

Insect protein remains an important part of the alternative protein landscape, driven by interest in sustainable food, feed and agricultural systems.

The sector is also now operating in a tougher commercial environment than it was during the initial growth phase of this sector which peaked in 2020, with pressure on financing, operating costs and scale-up. The previous report linked the post-2020 fall in filings to an investment pullback.

Filings have continued to ease since then. Excluding China, priority filings rose from 137 in 2015 to a peak of 296 in 2020 and stood at 255 in 2024. That is 10% down on 2023 and 13% below 2022 (292), but 20% above 2019 and nearly double 2015, so activity has settled above its pre-2020 level.

China is analysed separately because its volumes are far larger: 688 filings in 2024, or 73% of the combined total. Including China, filings rose 7% in 2024 (878 to 943).

Figure 1: 10-year trend (2015-2024) - global priority filings

Innovation landscape and technology trends

Yellow mealworm filings rose from 30 to 39 between 2023 and 2024, the highest level in the period analysed. Black soldier fly filings held at 64 in both years, after 56 in 2022, and remain the larger category, as in the previous year, although the gap in filing numbers between these two narrowed from 34 to 25.

Figure 2: 10-year trend (2015-2024) - black soldier fly versus mealworm priority filings by year

Geographic and competitive landscape

South Korea remains the leading jurisdiction outside China, with 101 filings in 2024. That is down 17% on 2023 (122) and below its 2020 peak of 135, but well ahead of any other jurisdiction. Public institutions still lead, with no noticeable shift towards commercial applicants.

European filings fell 29%, from 55 filings in 2023 to 39 in 2024, after peaking at 71 in 2021. This may be due to a scale-back following the loss of major companies such as Ynsect. The previous report suggested regulation was slowly enabling market development, but the latest data does not show this clearly: two house cricket novel foods had been authorised in the EU by 2023, yet European filings fell.

Filings in India rose from 12 to 17, a gain of 42%, with activity split between academic and commercial applicants and appearing mainly domestic.

Japan, the other growth centre named in the previous report, fell from 29 to 18; reflecting a relatively large batch of filings from Panasonic which was not repeated the following year. Filings in Russia (eight to 21) and Taiwan (eight to 14) also rose, while filings in the US were broadly flat (19 to 20).

Figure 3: 15-year trend (2010-2024) - insect protein priority filings by jurisdiction, excluding China

China’s filings rose from 595 to 688 after falling from 797 in 2018 to 569 in 2022, but remain below the 2016 peak of 827. Chinese filings peaked four years before the rest of the world (2020). China’s domestic patent landscape has distinctive characteristics, so comparisons with other jurisdictions should be made with care.

Figure 4: 15-year trend (2010-2024) - insect protein priority filings in China

Priority filings leading to international families fell 43% across the five jurisdictions shown, from 70 in 2023 to 40 in 2024, the lowest since 2016. Europe (33 to 20), China (15 to 8), the US (11 to seven) and Japan (nine to two) all fell; Korea (two to three) was the exception.

This could mean applicants are being more selective about seeking protection abroad or are focusing on domestic interests.

Figure 5: 10-year trend (2015-2024) - insect protein priority filings leading to international families

The competitive landscape remains fragmented. South Korea’s Rural Development Administration is the most consistent filer, with nine filings in both 2023 and 2024 and between four and nine every year since 2015, mostly on feed compositions for mealworms.

Foodyworm (Korea) filed four in each of the last two years, on insect-farming apparatus and medical applications of black soldier fly extracts. Innovafeed filed three, on methods and technologies to improve insect production, after nine in 2021.

Many smaller companies appear to file in bursts, which may reflect a focus on production. Dong Seoul College (three) is working on yellow mealworm in food and condiment manufacturing.

Three applicants had no earlier filings in the period of this analysis:

  • Grozny State Oil Technical University (six), whose filings all concern the use of “ecoprotein” from black soldier fly feed for livestock and poultry, leading the rise in filings from Russia
  • Lin Bingfeng (four), who appears to be a sole applicant from Taiwan, filing on rearing and breeding insects for high-protein feed
  • Reploid Group (four), with similar filings, some relating to frass.

The leading applicants range from human-food-focused (Dong Seoul College) to livestock-focused (Grozny State Oil Technical University).

Figure 6: 10-year trend (2015-2024) - insect protein priority filings by assignee

Commercial interpretation

The latest data points to a more selective sector. Filings excluding China have fallen two years running, international filings have dropped sharply, and the leading applicants’ filings are application-specific, covering feed compositions, farming apparatus and species-specific food products.

The data does not suggest innovation has stalled. Korea remains strong, filings in India and China both rose, mealworm filings reached a high point, and new applicants entered the leading group.

For innovators and IP professionals, production-related technologies still make up most filings (77% in 2024) and leading applicants are filing on specific applications. Protecting deployable, application-specific solutions therefore looks like the priority, more than broad platform concepts.

For innovators and IP professionals, production-related technologies still make up most filings (77% in 2024) and leading applicants are filing on specific applications. Protecting deployable, application-specific solutions therefore looks like the priority, more than broad platform concepts."

Looking ahead

Three developments warrant attention over the next three to five years:

  • Production focus. Production and automation technologies have made up between 69% and 86% of filings over the past 20 years, so innovation is likely to stay focused on practical production challenges.
  • India and China. Both rose in 2024 (India from 12 to 17, China from 595 to 688), so they may become more influential sources of patent activity if growth continues.
  • Mealworms. It will be worth watching whether the 2024 rise from 30 to 39 filings starts to close the gap with black soldier fly (64), which remains the larger category.

Patent activity alone cannot predict commercial success. The next phase of insect protein innovation is likely to depend on turning technical advances into economically viable production systems and defensible IP portfolios

Meet the attorneys

Oliver Manners

Patent Attorney

Learn more

James Myatt

Partner

Learn more